Menu

Clinuvel Pharmaceuticals Limited CUVL

Full chart Compare
Set alert

Price alert · CUVL

All alert types
5.10 USD -0.16 (-3.04%)

At closeNov 6, 2026, 4:00 PM EST

5.05 -0.05 -0.98%

After hours · Nov 6, 4:00 PM ET

5.08 Day range 5.23
4.81 52-week range 8.92
YTD
-39.86%
1 year
-28.97%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $4.79MGross Profit & Other Income → Net Income: $23.18MGross Profit & Other Income → Selling, General & Admin: $13.19MGross Profit & Other Income → Research & Development: $12.23MGross Profit & Other Income → Income Tax: $9.54MGross Profit → Gross Profit & Other Income: $53.34MRevenue → Gross Profit: $53.34MRevenue → Cost of Revenue: $10.98MOther Income$4.79MGross Profit$53.34MCost of Revenue$10.98MGross Profit & Other Income$58.13MNet Income$23.18MSelling, General & Admin$13.19MResearch & Development$12.23MIncome Tax$9.54MRevenue$64.32M

Latest period ending Jun 30, 2026 · select a line to chart its full history

CUVL annual income statement
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023
64.32M61.12M57.91M52.55M
53.34M49.61M47.17M41.95M
27.92M26.52M28.53M27.46M
23.18M23.12M23.35M20.51M
0.460.460.460.40
CUVL annual balance sheet
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023
13.91M18.06M23.30M—
203.98M176.74M153.69M—
15.36M20.00M18.66M—
1.34M332.72K574.28K—
188.62M156.74M135.03M—
CUVL annual cash flow
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023
12.91M27.30M23.75M25.13M
-25.64M-30.62M-19.25M-34.82M
-1.67M-1.87M-2.09M-1.33M
-1.06M-190.59K-3.65M-555.95K
-4.15M-5.24M2.26M-11.90M